JPS57188520A - Antihyperkalemia - Google Patents

Antihyperkalemia

Info

Publication number
JPS57188520A
JPS57188520A JP7326481A JP7326481A JPS57188520A JP S57188520 A JPS57188520 A JP S57188520A JP 7326481 A JP7326481 A JP 7326481A JP 7326481 A JP7326481 A JP 7326481A JP S57188520 A JPS57188520 A JP S57188520A
Authority
JP
Japan
Prior art keywords
formula
perorally
medicated
medicinal effect
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7326481A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6221329B2 (cs
Inventor
Yuji Maeda
Takami Fujii
Yasuhiko Kobayashi
Kenichi Saito
Tadaaki Kato
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP7326481A priority Critical patent/JPS57188520A/ja
Priority to US06/374,702 priority patent/US4442093A/en
Priority to IT21278/82A priority patent/IT1190824B/it
Priority to BE0/208097A priority patent/BE893193A/fr
Publication of JPS57188520A publication Critical patent/JPS57188520A/ja
Publication of JPS6221329B2 publication Critical patent/JPS6221329B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP7326481A 1981-05-15 1981-05-15 Antihyperkalemia Granted JPS57188520A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP7326481A JPS57188520A (en) 1981-05-15 1981-05-15 Antihyperkalemia
US06/374,702 US4442093A (en) 1981-05-15 1982-05-04 Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
IT21278/82A IT1190824B (it) 1981-05-15 1982-05-14 Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
BE0/208097A BE893193A (fr) 1981-05-15 1982-05-14 Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7326481A JPS57188520A (en) 1981-05-15 1981-05-15 Antihyperkalemia

Publications (2)

Publication Number Publication Date
JPS57188520A true JPS57188520A (en) 1982-11-19
JPS6221329B2 JPS6221329B2 (cs) 1987-05-12

Family

ID=13513135

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7326481A Granted JPS57188520A (en) 1981-05-15 1981-05-15 Antihyperkalemia

Country Status (1)

Country Link
JP (1) JPS57188520A (cs)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945681A (en) * 1988-05-20 1990-08-07 Toyoda Gosei Co., Ltd. Door weather strip for motor vehicle
JP2014088455A (ja) * 2006-06-21 2014-05-15 Proventiv Therapeutics Llc 二次性副甲状腺機能亢進症の治療及び予防方法
US10300078B2 (en) 2013-03-15 2019-05-28 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10493084B2 (en) 2014-08-07 2019-12-03 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11007204B2 (en) 2006-02-03 2021-05-18 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US11154509B2 (en) 2007-04-25 2021-10-26 Eirgen Pharma Ltd. Methods for controlled release oral dosage of a vitamin D compound
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945681A (en) * 1988-05-20 1990-08-07 Toyoda Gosei Co., Ltd. Door weather strip for motor vehicle
US11007204B2 (en) 2006-02-03 2021-05-18 Opko Renal, Llc Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US11911398B2 (en) 2006-02-03 2024-02-27 Opko Renal, Llc Treating Vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
JP2014088455A (ja) * 2006-06-21 2014-05-15 Proventiv Therapeutics Llc 二次性副甲状腺機能亢進症の治療及び予防方法
US9402855B2 (en) 2006-06-21 2016-08-02 Opko Renal, Llc Method of treating and preventing secondary hyperparathyroidism
JP2017002086A (ja) * 2006-06-21 2017-01-05 プロヴェンティヴ セラピュティックス リミテッド ライ 二次性副甲状腺機能亢進症の治療及び予防方法
US9913852B2 (en) 2006-06-21 2018-03-13 Opko Ireland Global Hodlings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US10668089B2 (en) 2006-06-21 2020-06-02 Opko Ireland Global Holdings, Ltd. Method of treating and preventing secondary hyperparathyroidism
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US11154509B2 (en) 2007-04-25 2021-10-26 Eirgen Pharma Ltd. Methods for controlled release oral dosage of a vitamin D compound
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
US10300078B2 (en) 2013-03-15 2019-05-28 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US11253528B2 (en) 2013-03-15 2022-02-22 Eirgen Pharma Ltd. Stabilized modified release Vitamin D formulation and method of administering same
US10357502B2 (en) 2013-03-15 2019-07-23 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US10350224B2 (en) 2013-03-15 2019-07-16 Opko Ireland Global Holdings, Ltd. Stabilized modified release vitamin D formulation and method of administering same
US11007205B2 (en) 2014-08-07 2021-05-18 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US10493084B2 (en) 2014-08-07 2019-12-03 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11738033B2 (en) 2014-08-07 2023-08-29 Eirgen Pharma Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11173168B2 (en) 2016-03-28 2021-11-16 Eirgen Pharma Ltd. Methods of treating vitamin D insufficiency in chronic kidney disease
US12208106B2 (en) 2016-03-28 2025-01-28 Eirgen Pharma Ltd. Methods of vitamin D treatment

Also Published As

Publication number Publication date
JPS6221329B2 (cs) 1987-05-12

Similar Documents

Publication Publication Date Title
NZ295211A (en) Topical aqueous gel containing a water-soluble cellulose derivative, propylene glycol & drug(s) for haemorrhoids
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
HK48392A (en) Drug particles having constant release and immediate release
WO1998029110A3 (en) Formulation and method for treating neoplasms by inhalation
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
EP0107214A3 (en) Pharmaceutical compositions containing benzoyl-phenyl ureas with anti-tumour activity
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
IE830777L (en) Compositions of imazolil and hexamidine isethionate for acne
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS57188520A (en) Antihyperkalemia
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
JPS5332124A (en) Carcinostatic agent
DE3263832D1 (en) Gallium chloride, an anti-cancer drug
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
EP0472033A3 (en) 3,5-diiod-l-thyronin for tsh-suppression and the treatment of goiter
DE3163920D1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
JPS5551019A (en) Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof
JPS5218832A (en) Method of making cosmetic preparation
JPS5513252A (en) Preventive and remedy for swine dysentry
JPS5793913A (en) Enhancing agent for spermous vital power
JPS5484034A (en) Anti-tumor agent
JPS577422A (en) Crocosmia aurea "plach"
HUP9900521A2 (hu) Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására